載入...
Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia
OBJECTIVES: Teicoplanin, a glycopeptide, is regarded as among the drug choices for methicillin-resistant Staphylococcus aureus (MRSA) infections. Few studies have evaluated the relationship between teicoplanin minimal inhibitory concentrations (MICs) and outcomes among patients with serious MRSA inf...
Na minha lista:
發表在: | Infect Drug Resist |
---|---|
Main Authors: | , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Dove Medical Press
2018
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6101025/ https://ncbi.nlm.nih.gov/pubmed/30147349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S171236 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|